Cytosorbents Corporation (CTSO)
NASDAQ: CTSO · Real-Time Price · USD
1.130
-0.030 (-2.59%)
Apr 25, 2025, 12:18 PM EDT - Market open
Cytosorbents Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 3.28 | 14.13 | 22.14 | 52.14 | 71.42 | Upgrade
|
| Cash & Short-Term Investments | 3.28 | 14.13 | 22.14 | 52.14 | 71.42 | Upgrade
|
| Cash Growth | -76.79% | -36.19% | -57.53% | -27.00% | 483.87% | Upgrade
|
| Receivables | 7.32 | 6.06 | 5.66 | 4.52 | 5.16 | Upgrade
|
| Inventory | 2.73 | 3.38 | 3.46 | 4.77 | 2.67 | Upgrade
|
| Prepaid Expenses | 3.27 | 1.83 | 2.49 | 2.87 | 3.2 | Upgrade
|
| Restricted Cash | 5 | - | - | - | - | Upgrade
|
| Total Current Assets | 21.6 | 25.4 | 33.76 | 64.3 | 82.45 | Upgrade
|
| Property, Plant & Equipment | 20.51 | 22.12 | 23.35 | 18.57 | 3.15 | Upgrade
|
| Other Intangible Assets | 3.75 | 3.91 | 4.39 | 4.7 | 4.22 | Upgrade
|
| Other Long-Term Assets | 1.51 | 1.54 | 1.73 | 1.94 | 0.13 | Upgrade
|
| Total Assets | 47.37 | 52.96 | 63.23 | 89.52 | 89.95 | Upgrade
|
| Accounts Payable | 3.34 | 3.8 | 1.66 | 2.81 | 1.84 | Upgrade
|
| Accrued Expenses | 4.75 | 4.99 | 6.43 | 8.37 | 7.14 | Upgrade
|
| Current Portion of Long-Term Debt | - | 2.5 | - | - | - | Upgrade
|
| Current Portion of Leases | 0.45 | 0.37 | 0.11 | 0.57 | 0.45 | Upgrade
|
| Current Unearned Revenue | 0.42 | 1.38 | 1.52 | 1.95 | 0.73 | Upgrade
|
| Other Current Liabilities | 0.87 | 0.99 | - | - | - | Upgrade
|
| Total Current Liabilities | 9.82 | 14.04 | 9.71 | 13.69 | 10.15 | Upgrade
|
| Long-Term Debt | 14 | 2.54 | 5 | - | - | Upgrade
|
| Long-Term Leases | 12.44 | 12.9 | 13.14 | 13.25 | 0.58 | Upgrade
|
| Total Liabilities | 36.26 | 29.48 | 27.86 | 26.94 | 10.73 | Upgrade
|
| Common Stock | 0.05 | 0.05 | 0.04 | 0.04 | 0.04 | Upgrade
|
| Additional Paid-In Capital | 310.81 | 306.19 | 287 | 283.19 | 277.53 | Upgrade
|
| Retained Earnings | -304.01 | -283.29 | -254 | -221.19 | -196.63 | Upgrade
|
| Comprehensive Income & Other | 4.25 | 0.53 | 2.33 | 0.53 | -1.73 | Upgrade
|
| Shareholders' Equity | 11.11 | 23.48 | 35.37 | 62.58 | 79.22 | Upgrade
|
| Total Liabilities & Equity | 47.37 | 52.96 | 63.23 | 89.52 | 89.95 | Upgrade
|
| Total Debt | 26.89 | 18.31 | 18.25 | 13.82 | 1.03 | Upgrade
|
| Net Cash (Debt) | -23.61 | -4.18 | 3.89 | 38.32 | 70.39 | Upgrade
|
| Net Cash Growth | - | - | -89.84% | -45.57% | - | Upgrade
|
| Net Cash Per Share | -0.43 | -0.09 | 0.09 | 0.88 | 1.81 | Upgrade
|
| Filing Date Shares Outstanding | 62.5 | 54.29 | 43.66 | 43.51 | 43.26 | Upgrade
|
| Total Common Shares Outstanding | 54.83 | 54.24 | 43.64 | 43.48 | 43.22 | Upgrade
|
| Working Capital | 11.78 | 11.36 | 24.05 | 50.61 | 72.3 | Upgrade
|
| Book Value Per Share | 0.20 | 0.43 | 0.81 | 1.44 | 1.83 | Upgrade
|
| Tangible Book Value | 7.36 | 19.57 | 30.98 | 57.88 | 74.99 | Upgrade
|
| Tangible Book Value Per Share | 0.13 | 0.36 | 0.71 | 1.33 | 1.74 | Upgrade
|
| Machinery | 6.94 | 6.87 | 6.44 | 7.29 | 5.4 | Upgrade
|
| Leasehold Improvements | 6.28 | 6.22 | 6.2 | 2.62 | 0.97 | Upgrade
|
Updated Nov 7, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.